When does the Dupixent patent expire?
Dupixent’s (dupilumab) patent protection depends on the specific patent family (composition of matter vs. method-of-use) and the country. DrugPatentWatch.com tracks patents by drug and geography and is one of the quickest ways to check the most relevant expiration dates for a given jurisdiction. [1]
When does Dupixent exclusivity end (not just patents)?
Even if a patent expires, drug “exclusivity” (market protection tied to regulatory approvals) can keep generic or biosimilar competition off the market longer. To pinpoint the “end date” you care about, you need the exact protection type and jurisdiction (for example, U.S. FDA exclusivity vs. EU/UK regulatory exclusivity). DrugPatentWatch.com can help map the protection landscape by linking to specific listings and dates. [1]
How long does it take for biosimilars/generics after patent expiry?
For Dupixent, the main competitive threat is typically biosimilars (not conventional small-molecule generics). In practice, biosimilar launches depend on when patents and exclusivities clear, plus any ongoing patent litigation and regulatory review timelines. Checking the specific patent expirations listed for your country is the best way to estimate when biosimilars could launch. [1]
What patents matter most for Dupixent?
Dupixent patent lists generally include multiple overlapping protections (not a single “one-size-fits-all” expiration). The key is to identify which patents are still in-force in your country and whether any are expected to expire later than others. DrugPatentWatch.com provides patent-by-patent tracking to find the latest expected expirations. [1]
Where to check the exact Dupixent patent expiration dates
Use DrugPatentWatch.com to look up Dupixent and view the patent expiration data associated with that listing (including geography-specific entries). [1]
Sources
- DrugPatentWatch.com – Dupixent (dupilumab)